2023 Feb 9;13(2):342. doi: 10.3390/biom13020342.

Spiro KhouryJenny ColasVéronique BreuilEva Kosek, Aisha S AhmedCamilla I SvenssonFabien MarchandEmmanuel DevalThierry Ferreira


Lipids, especially lysophosphatidylcholine LPC16:0, have been shown to be involved in chronic joint pain through the activation of acid-sensing ion channels (ASIC3). The aim of the present study was to investigate the lipid contents of the synovial fluids from controls and patients suffering from chronic joint pain in order to identify characteristic lipid signatures associated with specific joint diseases. For this purpose, lipids were extracted from the synovial fluids and analyzed by mass spectrometry. Lipidomic analyses identified certain choline-containing lipid classes and molecular species as biomarkers of chronic joint pain, regardless of the pathology, with significantly higher levels detected in the patient samples. Moreover, correlations were observed between certain lipid levels and the type of joint pathologies. Interestingly, LPC16:0 levels appeared to correlate with the metabolic status of patients while other choline-containing lipids were more specifically associated with the inflammatory state. Overall, these data point at selective lipid species in synovial fluid as being strong predictors of specific joint pathologies which could help in the selection of the most adapted treatment.

Trial registration: NCT01867840.

Keywords: chronic joint pain; inflammation; lipidomics; metabolic status; synovial fluid.

Identification of Lipid Biomarkers for Chronic Joint Pain Associated with Different Joint Diseases